Clinical Trial Update: Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the recombinant VSV-based Marburg virus vaccine candidate PHV01 in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marburg Virus Disease

Drugs mentioned

• PHV01 (recombinant vesicular stomatitis virus-based Marburg virus vaccine candidate)

Snippet

Sponsor: Public Health Vaccines LLC | Conditions: Marburg Virus Disease | Phase 1 | Status: COMPLETED